» Articles » PMID: 21427658

The Importance of Quality-of-life Assessment in the Management of Patients with Multiple Sclerosis. Recommendations from the Middle East MS Advisory Group

Overview
Specialty Neurology
Date 2011 Mar 24
PMID 21427658
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) has a major negative impact on patients` health-related quality of life (QoL). A group of MS experts in the Middle East met to develop recommendations for the routine assessment of QoL in patients with MS. The group recommended that patients need to be assessed once a year using the multiple sclerosis international QoL questionnaire (MusiQoL), which is available in Arabic. Assessments should be made when patients are relapse-free to avoid confounding factors. At other clinic visits, patients` QoL should also be monitored, alongside their physical assessment, using open and structured questions on disease features that are likely to affect their QoL. This approach should allow long-term monitoring of key features of MS that are important to patients` well being, and aid decision-making regarding their management, including the use of disease-modifying drugs.

Citing Articles

A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon -1a.

Al Jumah M, Kojan S, Alroughani R, Cupler E, Bohlega S, Daif A Mult Scler Int. 2021; 2021:6681431.

PMID: 33747564 PMC: 7943271. DOI: 10.1155/2021/6681431.


Factors affecting MS patients' health-related quality of life and measurement challenges in Lebanon and the MENA region.

Farran N, Safieddine B, Bayram M, Abi Hanna T, Massouh J, AlKhawaja M Mult Scler J Exp Transl Clin. 2020; 6(1):2055217319848467.

PMID: 31976081 PMC: 6956607. DOI: 10.1177/2055217319848467.


Quality of life among multiple sclerosis patients in Saudi Arabia.

Algahtani H, Shirah B, AlZahrani F, Abobaker H, Alghanaim N, Manlangit Jr J Neurosciences (Riyadh). 2017; 22(4):261-266.

PMID: 29057850 PMC: 5946374. DOI: 10.17712/nsj.2017.4.20170273.


Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East.

Achiron A, Aref H, Inshasi J, Harb M, Alroughani R, Bijarnia M BMC Neurol. 2017; 17(1):150.

PMID: 28784108 PMC: 5547540. DOI: 10.1186/s12883-017-0913-3.


Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis.

Moghaddam Tabrizi F, Radfar M Int J MS Care. 2015; 17(6):268-74.

PMID: 26664332 PMC: 4673919. DOI: 10.7224/1537-2073.2014-046.